Results 121 to 130 of about 155,199 (206)

Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients

Lupus, 2021
Background Age at disease onset may modulate systemic lupus erythematosus (SLE), but its relation to cutaneous/extracutaneous manifestation remains understudied.
K. Chanprapaph   +5 more
semanticscholar   +1 more source

Anifrolumab for treatment of refractory cutaneous lupus erythematosus

Clincal and Experimental Dermatology, 2022
Cutaneous lupus erythematosus (CLE) is a spectrum of skin changes related to systemic lupus erythematosus (SLE), a family of autoimmunity manifesting characteristic multisystem inflammation and damage. Treatment of CLE continues to evolve, especially for
F. Blum, Ashwath Sampath, G. T. Foulke
semanticscholar   +1 more source

Cutaneous lupus erythematosus

Seminars in Cutaneous Medicine and Surgery, 2001
Lupus erythematosus (LE) has many different clinical manifestations including a variety of cutaneous findings. Some of the cutaneous manifestations are not specific for LE, such as photosensitivity reactions, oral ulcers, alopecia, urticaria, vasculitis, vesiculo-bullous lesions, acral changes, cutaneous mucinoses, and cutaneous calcinosis.
S, Pérez Santos   +4 more
openaire   +4 more sources

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021

British Journal of Dermatology, 2021
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of cutaneous lupus erythematosus (CLE) in the presence or absence of systemic lupus erythematosus (SLE) in adults, young people and ...
D. O'Kane   +10 more
semanticscholar   +1 more source

Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia

Clincal and Experimental Dermatology, 2021
With great interest we read the recently published article by Joos et al.1 on the successful use of baricitinib for cutaneous lupus erythematosus (CLE).
A. Kreuter   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy